Shein opens order book for HKEX listing
The Chinese online fashion giant, which is targeting a $27bn valuation, has a presence in 160 countries.
August 24, 2026
Hansoh Pharmaceutical Group launched on Thursday Hong Kong’s second-largest initial public offering this year, looking for as much as HK$7.8 billion ($1 billion) as the Chinese generic drug manufacturer tries to draw investor attention away from a focus on biotech companies.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].